166 related articles for article (PubMed ID: 6823373)
1. Clinical significance of estrogen and progestin receptors in ovarian cancer.
Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
[TBL] [Abstract][Full Text] [Related]
2. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
[TBL] [Abstract][Full Text] [Related]
3. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic correlations of estrogen and progestin receptor protein in epithelial ovarian carcinomas.
Schwartz PE; Merino MJ; Livolsi VA; Lawrence R; MacLusky N; Eisenfeld A
Obstet Gynecol; 1985 Sep; 66(3):428-33. PubMed ID: 4022502
[TBL] [Abstract][Full Text] [Related]
5. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
Rose PG; Reale FR; Longcope C; Hunter RE
Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
[TBL] [Abstract][Full Text] [Related]
7. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
Fischer-Colbrie J; Witt A; Heinzl H; Speiser P; Czerwenka K; Sevelda P; Zeillinger R
Anticancer Res; 1997; 17(1B):613-9. PubMed ID: 9066588
[TBL] [Abstract][Full Text] [Related]
8. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
Langdon SP; Gabra H; Bartlett JM; Rabiaz GJ; Hawkins RA; Tesdale AL; Ritchie AA; Miller WR; Smyth JF
Clin Cancer Res; 1998 Sep; 4(9):2245-51. PubMed ID: 9748145
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptors in ovarian epithelial carcinoma.
Schwartz PE; LiVolsi VA; Hildreth N; MacLusky NJ; Naftolin FN; Eisenfeld AJ
Obstet Gynecol; 1982 Feb; 59(2):229-38. PubMed ID: 7078869
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progestin receptors in an ovarian ependymoma.
Auerbach R; Mittal K; Schwartz PE
Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1043-5. PubMed ID: 2836769
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival.
Bizzi A; Codegoni AM; Landoni F; Marelli G; Marsoni S; Spina AM; Torri W; Mangioni C
Cancer Res; 1988 Nov; 48(21):6222-6. PubMed ID: 3167868
[TBL] [Abstract][Full Text] [Related]
12. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
Ordi J; Schammel DP; Rasekh L; Tavassoli FA
Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
14. [Estrogen and progesterone receptors in malignant ovarian neoplasms].
Teufel G; Geyer H; de Gregorio G; Fuchs A; Kleine W; Pfleiderer A
Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):732-40. PubMed ID: 6559148
[TBL] [Abstract][Full Text] [Related]
15. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy.
Richman CM; Holt JA; Lorincz MA; Herbst AL
Obstet Gynecol; 1985 Feb; 65(2):257-63. PubMed ID: 3969239
[TBL] [Abstract][Full Text] [Related]
16. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary.
Vierikko P; Kauppila A; Vihko R
Int J Cancer; 1983 Oct; 32(4):413-22. PubMed ID: 6311758
[TBL] [Abstract][Full Text] [Related]
17. Multiple parameter analyses of human ovarian cancer: morphology, immunohistochemistry, steroid hormone receptors and aromatase.
Kühnel R; Rao BR; Poels LG; Delemarre JF; Kenemans P; Stolk JG
Anticancer Res; 1988; 8(2):281-6. PubMed ID: 3364939
[TBL] [Abstract][Full Text] [Related]
18. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.
Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA
Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656
[TBL] [Abstract][Full Text] [Related]
19. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
